TP53 and Ewing sarcoma: Furthermore, studies highlighting the recurrent frequencies of, albeit few, somatic mutations in TP53 (5%-20%), STAG2 genes (20%) and homozygous deletions of CDKN2A (10%-30%) have been described in ES pathogenesis [4–6].